Moises Zanetti, Author at JCR Pharmaceuticals

Announcement of executive appointments and organizational changes

by Moises Zanetti

JCR establishes Advanced Biopharmaceutical Research Institute

by Moises Zanetti

JCR Pharmaceuticals supports Rare Disease Day 2026

by Moises Zanetti

JCR organizes and conducts API plant tour for individual shareholders

by Moises Zanetti

JCR Pharmaceuticals’ research presentations at WORLDSymposium™ 2026 showcase data from its investigational treatments for lysosomal storage disorders

by Moises Zanetti

FY2025 third quarter results briefing session script

by Moises Zanetti

FY2025-Q3 financial report (Oct. 1-Dec. 31, 2025)

by Moises Zanetti

Revision of consolidated financial forecasts for fiscal year ended March 31, 2026

by Moises Zanetti

Recognition of subsidy income as extraordinary income

by Moises Zanetti

FY2025 third quarter results briefing session material

by Moises Zanetti